Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)
China · Delayed Price · Currency is CNY 9.63
+0.47 (5.13%)
Apr 29, 2026, 3:08 PM CST
SHE:300016 Revenue
In the year 2025, Beijing Beilu Pharmaceutical had annual revenue of 1.21B CNY with 22.54% growth. Beijing Beilu Pharmaceutical had revenue of 332.59M in the quarter ending December 31, 2025, with 31.03% growth.
Revenue
1.21B
Revenue Growth
+22.54%
P/S Ratio
4.28
Revenue / Employee
1.03M
Employees
1,173
Market Cap
5.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.21B | 221.72M | 22.54% |
| Dec 31, 2024 | 983.55M | 92.84M | 10.42% |
| Dec 31, 2023 | 890.72M | 124.84M | 16.30% |
| Jan 1, 2023 | 765.88M | -94.02M | -10.93% |
| Jan 1, 2022 | 859.91M | 32.57M | 3.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.63B |
| Jianmin Pharmaceutical Group | 3.35B |
| Zhejiang Starry Pharmaceutical | 2.39B |
| Fuan Pharmaceutical (Group) | 1.68B |
| Tianjin Lisheng Pharmaceutical | 1.35B |
| Bide Pharmatech | 1.32B |
| Teyi Pharmaceutical Group Co.,Ltd | 924.53M |
| Nanjing Hicin Pharmaceutical | 688.74M |